Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing

American Journal of the Medical Sciences

Volumn 345, Issue 2, 2013, Pages 143-148

  Kalokhe, Ameeta S ^a   Shafiq, Majid ^b   Lee, James C ^a   Ray, Susan M ^a   Wang, Yun F ^a   Metchock, Beverly ^c   Anderson, Albert M ^a   Ly T Nguyen, Minh ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Drug susceptibility testing; Molecular diagnostic tools; Multidrug resistance; Tuberculosis

Indexed keywords

BACTERIAL DNA; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM CULTURE; DNA ISOLATION; DNA SEQUENCE; DRUG MECHANISM; GENE FREQUENCY; GENE MUTATION; GENOTYPING TECHNIQUE; MOLECULAR BEACON; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS;

EID: 84873137079     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31825d32c6     Document Type: Review

References (42)

1. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization; 2010. p. 19
2. Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010;181:80-6
3. Sandgren A, Strong M, Muthukrishnan P, et al. Tuberculosis drug resistance mutation database. PLoS Med 2009;6:e2
4. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44
5. Vilcheze C, Jacobs WR Jr. The mechanism of isoniazid killing: Clarity through the scope of genetics. Annu Rev Microbiol 2007;61:35-50
6. Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol 2006;62:1220-7
7. Zhang Y, Heym B, Allen B, et al. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358: 591-3
8. Centers for Disease Control and Prevention. Report of expert consultations on rapid molecular testing to detect drug-resistant tuberculosis in the United States. Atlanta, Georgia: Centers for Disease Control and Prevention; 2009
9. Hazbon MH, Brimacombe M, Bobadilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006;50:2640-9
10. Cohen T, Becerra MC, Murray MB. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb Drug Resist 2004;10:280-5
11. Dalla Costa ER, Ribeiro MO, Silva MS, et al. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol 2009;9:39
12. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicinresistance mutations in Mycobacterium tuberculosis. Lancet 1993;341: 647-50
13. Jin DJ, Gross CA. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 1988;202:45-58
14. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271: 665-71
15. Shah NS, Lan NT, Huyen MN, et al. Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam. Int J Tuberc Lung Dis 2009;13:247-52
16. Traore H, Fissette K, Bastian I, et al. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000;4:481-4
17. Musser JM. Antimicrobial agent resistance in mycobacteria: Molecular genetic insights. Clin Microbiol Rev 1995;8:496-514
18. Arnold C, Westland L, Mowat G, et al. Single-nucleotide polymorphism- based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum. Clin Microbiol Infect 2005;11:122-30
19. Francis J. Curry National Tuberculosis Center. Drug-resistant tuberculosis: A survival guide for clinicians, 2nd ed. San Francisco, California: Francis J. Curry National Tuberculosis Center; 2008. p. 1-266
20. Rusch-Gerdes S, Domehl C, Nardi G, et al. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol 1999;37:45-8
21. Bemer P, Palicova F, Rusch-Gerdes S, et al. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960
22. system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002;40:150-4
23. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis. Eur Respir J 2008;32:1165-74
24. Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997;41:2093-8
25. Brossier F, Veziris N, Jarlier V, et al. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis 2009;13:260-5
26. Morgan M, Kalantri S, Flores L, et al. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis. BMC Infect Dis 2005;5:62
27. Makinen J, Marttila HJ, Marjamaki M, et al. Comparison of two commercially available DNA line probe assays for detection of multidrug- resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44: 350-2
28. Varma-Basil M, El-Hajj H, Colangeli R, et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J Clin Microbiol 2004;42:5512-6
29. Lin SY, Probert W, Lo M, et al. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol 2004;42:4204-8
30. El-Hajj HH, Marras SA, Tyagi S, et al. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001;39:4131-7
31. Piatek AS, Telenti A, Murray MR, et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: Implications for rapid susceptibility testing. Antimicrob Agents Chemother 2000;44:103-10
32. Piatek AS, Tyagi S, Pol AC, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 1998;16:359-63
33. Gomez DI, Fisher-Hoch SP, Bordt AS, et al. Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria. Diagn Microbiol Infect Dis 2010;67:37-46
34. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363: 1005-15
35. Bravo LT, Tuohy MJ, Ang C, et al. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. J Clin Microbiol 2009;47:3985-90
36. Zhao JR, Bai YJ, Zhang QH, et al. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2005;51:135-7
37. Marttila HJ, Makinen J, Marjamaki M, et al. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 2009;28:33-8
38. Zhao JR, Bai YJ, Wang Y, et al. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutolresistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005;9: 328-32
39. Jureen P, Engstrand L, Eriksson S, et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. J Clin Microbiol 2006;44:1925-9
40. Halse TA, Edwards J, Cunningham PL, et al. Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J Clin Microbiol 2010;48:1182-8
41. Van Deun A, Barrera L, Bastian I, et al. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol 2009;47:3501-6
42. Kalokhe AS, Shafiq M, Lee JC, et al. Discordance in Mycobacterium tuberculosis rifampin susceptibility. Emerg Infect Dis 2012;18:537-9.